Depth of experience that only the highest surgical volume can provide.
Shanghai Pulmonary Hospital performs more thoracic surgeries than virtually any center in the world. Our surgeons operate 30–40 times per day across 12 operating rooms, bringing an unmatched depth of experience to both common and rare thoracic conditions.
Shanghai Pulmonary Hospital is a pioneer in video-assisted thoracoscopic surgery (VATS) and uniportal techniques in China. Our surgeons routinely perform complex thoracic procedures through a single small incision — typically 3–4 cm.
Benefits for patients include significantly less post-operative pain, shorter hospital stays (typically 3–5 days versus 7–10 for open surgery), faster return to normal activities, and minimal scarring.
Our minimally invasive approach is applied across the full spectrum of thoracic conditions, from wedge resections for small nodules to complex lobectomies and segmentectomies for lung cancer.
As a national clinical key specialty in oncology, Shanghai Pulmonary Hospital offers the full continuum of lung cancer care — from screening and early detection through surgical treatment, radiation therapy, immunotherapy, and targeted molecular therapy.
Our multidisciplinary tumor board brings together thoracic surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists to develop individualized treatment plans for each patient.
With one of the world's highest case volumes, our team has deep experience with both common and rare presentations, including complex cases involving central tumors, chest wall invasion, and oligometastatic disease.
With the widespread adoption of CT screening, pulmonary nodules — particularly ground-glass nodules (GGNs) — are being discovered in increasing numbers worldwide. Many patients face uncertainty about whether their nodule requires monitoring, biopsy, or surgical intervention.
Shanghai Pulmonary Hospital's experts authored China's national consensus guidelines for managing ground-glass nodules suspected as lung adenocarcinoma, published in collaboration with leading cancer centers across China.
Our Pulmonary Nodule Fast-Track program provides a definitive answer within 72 hours: high-resolution CT imaging, expert multidisciplinary review, and a clear recommendation for your next steps.
Shanghai Pulmonary Hospital has been at the forefront of lung transplantation in China since performing Asia's first allogeneic lung transplant in an elderly patient in 2003.
Our transplant program, supported by the Shanghai Lung Transplant Engineering Research Center, offers evaluation and surgical management for patients with end-stage lung disease, including pulmonary fibrosis, COPD, and pulmonary hypertension.
Comprehensive non-surgical pulmonary expertise including interstitial lung disease, COPD, asthma, and complex infectious disease. A Shanghai clinical key specialty.
Shanghai's designated TB treatment center with a dedicated on-campus facility, continuing a specialty dating back to our 1933 founding mission.
As Shanghai's designated occupational disease prevention hospital, we have unique expertise in pneumoconiosis, occupational poisoning, radiation injury, and environmental lung conditions.
A national "flagship" department combining traditional Chinese medicine with modern Western treatment approaches for respiratory and pulmonary conditions.